Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q2 2024 ▲▼ | Q3 2024 ▲▼ | Change ▲▼ | Q2 2024 ▲▼ | Q3 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Tarsus Pharmaceuticals, Inc.(TARS) | 800,277 | 1,030,277 | +230,000 | $21.75M | $33.89M | 10.52% | +$12.13M |
| Crinetics Pharmaceuticals In | 588,818 | 426,913 | -161,905 | $26.37M | $21.82M | 6.77% | -$4.56M |
| Enliven Therapeutics Inc | 586,552 | 499,566 | -86,986 | $13.71M | $12.76M | 3.96% | -$948.8K |
| Arcus Biosciences, Inc.(RCUS) | 145,000 | 744,000 | +599,000 | $2.21M | $11.38M | 3.53% | +$9.17M |
| Viridian Therapeutics, Inc.(VRDN) | 0 | 499,977 | +499,977 | $0 | $11.37M | 3.53% | +$11.37M |
| Insmed Incorporated(INSM) | 47,835 | 154,835 | +107,000 | $3.20M | $11.30M | 3.51% | +$8.10M |
| Soleno Therapeutics Inc | 445,451 | 221,437 | -224,014 | $18.17M | $11.18M | 3.47% | -$6.99M |
| Ultragenyx Pharmaceutical Inc.(RARE) | 0 | 179,000 | +179,000 | $0 | $9.94M | 3.09% | +$9.94M |
| Avalo Therapeutics, Inc.(AVTX) | 54,730 | 970,359 | +915,629 | $682.5K | $9.22M | 2.86% | +$8.54M |
| Cytokinetics, Incorporated(CYTK) | 170,147 | 170,147 | 0 | $9.22M | $8.98M | 2.79% | -$234.8K |
| Spyre Therapeutics, Inc.(SYRE) | 0 | 302,247 | +302,247 | $0 | $8.89M | 2.76% | +$8.89M |
| Catalyst Pharmaceuticals Inc | 518,386 | 417,850 | -100,536 | $8.03M | $8.31M | 2.58% | +$277.1K |
| Tectonic Therapeutic, Inc.(TECX) | 62,836 | 267,145 | +204,309 | $1.03M | $8.09M | 2.51% | +$7.06M |
| Blueprint Medicines Corp | 0 | 85,000 | +85,000 | $0 | $7.86M | 2.44% | +$7.86M |
| BridgeBio Pharma, Inc.(BBIO) | 332,013 | 285,613 | -46,400 | $8.41M | $7.27M | 2.26% | -$1.14M |
| Sarepta Therapeutics, Inc.(SRPT) | 203,612 | 54,176 | -149,436 | $32.17M | $6.77M | 2.10% | -$25.40M |
| Corbus Pharmaceuticals Holdings, Inc.(CRBP) | 309,540 | 284,715 | -24,825 | $14.01M | $5.87M | 1.82% | -$8.13M |
| Nurix Therapeutics, Inc.(NRIX) | 440,500 | 260,000 | -180,500 | $9.19M | $5.84M | 1.81% | -$3.35M |
| Nuvalent Inc | 151,601 | 52,238 | -99,363 | $11.50M | $5.34M | 1.66% | -$6.16M |
| Structure Therapeutics IncADS | 0 | 115,200 | +115,200 | $0 | $5.06M | 1.57% | +$5.06M |
| Relay Therapeutics, Inc.(RLAY) | 0 | 693,350 | +693,350 | $0 | $4.91M | 1.52% | +$4.91M |
| LENZ Therapeutics, Inc.(LENZ) | 204,513 | 204,513 | 0 | $3.54M | $4.86M | 1.51% | +$1.32M |
| Capricor Therapeutics, Inc.(CAPR) | 0 | 300,000 | +300,000 | $0 | $4.56M | 1.42% | +$4.56M |
| Wave Life Sciences, Inc.SHS(WVE) | 575,088 | 544,265 | -30,823 | $2.87M | $4.46M | 1.39% | +$1.59M |
| Rezolute, Inc.(RZLT) | 903,744 | 887,230 | -16,514 | $3.89M | $4.30M | 1.34% | +$417.0K |
| Amgen Inc.(AMGN) | 38,300 | 13,300 | -25,000 | $11.97M | $4.29M | 1.33% | -$7.68M |
| Xenon Pharmaceuticals Inc.(XENE) | 107,187 | 107,187 | 0 | $4.18M | $4.22M | 1.31% | +$40.7K |
| Evolus, Inc.(EOLS) | 0 | 258,279 | +258,279 | $0 | $4.18M | 1.30% | +$4.18M |
| Abeona Therapeutics Inc.(ABEO) | 768,593 | 583,593 | -185,000 | $3.26M | $3.69M | 1.15% | +$429.5K |
| Rocket Pharmaceuticals, Inc.(RCKT) | 197,096 | 197,096 | 0 | $4.24M | $3.64M | 1.13% | -$603.1K |
| Pyxis Oncology, Inc.(PYXS) | 1,662,408 | 957,408 | -705,000 | $5.50M | $3.51M | 1.09% | -$1.99M |
| Silence Therapeutics plcADS(SLN) | 506,665 | 587,343 | +80,678 | $3.29M | $3.37M | 1.05% | +$81.0K |
| Acelyrin Inc | 1,475,074 | 677,074 | -798,000 | $6.51M | $3.34M | 1.04% | -$3.17M |
| Cybin D/B/A Helus Pharma(HELP) | 0 | 367,195 | +367,195 | $0 | $3.26M | 1.01% | +$3.26M |
| CervoMed Inc.(CRVO) | 237,345 | 202,345 | -35,000 | $4.06M | $2.95M | 0.92% | -$1.11M |
| Tourmaline Bio Inc | 108,483 | 108,483 | 0 | $1.40M | $2.79M | 0.87% | +$1.39M |
| Terns Pharmaceuticals Inc | 458,497 | 308,497 | -150,000 | $3.12M | $2.57M | 0.80% | -$549.5K |
| Alnylam Pharmaceuticals, Inc.(ALNY) | 0 | 8,741 | +8,741 | $0 | $2.40M | 0.75% | +$2.40M |
| Lexeo Therapeutics, Inc.(LXEO) | 0 | 257,216 | +257,216 | $0 | $2.33M | 0.72% | +$2.33M |
| Mineralys Therapeutics, Inc.(MLYS) | 0 | 180,000 | +180,000 | $0 | $2.18M | 0.68% | +$2.18M |
| Reneo Pharmaceuticals Inc | 0 | 1,025,668 | +1,025,668 | $0 | $1.74M | 0.54% | +$1.74M |
| Nektar Therapeutics(NKTR) | 1,312,405 | 1,312,405 | 0 | $1.63M | $1.71M | 0.53% | +$78.7K |
| Monte Rosa Therapeutics, Inc.(GLUE) | 0 | 311,593 | +311,593 | $0 | $1.65M | 0.51% | +$1.65M |
| BeOne Medicines AGADR(ONC) | 0 | 88,167 | +88,167 | $0 | $1.64M | 0.51% | +$1.64M |
| Achilles Therapeutics PlcADS | 1,443,181 | 1,443,181 | 0 | $1.18M | $1.47M | 0.46% | +$295.9K |
| iBio, Inc.CON NEW(IBIO) | 600,000 | 600,000 | 0 | $1.27M | $1.33M | 0.41% | +$66.0K |
| COMPASS Pathways plcADS(CMPS) | 302,908 | 202,908 | -100,000 | $1.83M | $1.28M | 0.40% | -$551.2K |
| Kodiak Sciences Inc.(KOD) | 476,586 | 476,586 | 0 | $1.12M | $1.24M | 0.39% | +$123.9K |
| Marinus Pharmaceuticals Inc | 706,154 | 706,154 | 0 | $826.2K | $1.24M | 0.39% | +$416.6K |
| Roivant Sciences Ltd.SHS(ROIV) | 100,609 | 100,609 | 0 | $1.06M | $1.16M | 0.36% | +$97.6K |
| Olema Pharmaceuticals, Inc.(OLMA) | 0 | 92,000 | +92,000 | $0 | $1.10M | 0.34% | +$1.10M |
| InflaRx N.V.(IFRX) | 704,987 | 704,987 | 0 | $1.23M | $1.08M | 0.33% | -$148.0K |
| Sagimet Biosciences Inc.COM SER A(SGMT) | 412,565 | 387,565 | -25,000 | $1.41M | $1.07M | 0.33% | -$337.4K |
| Jasper Therapeutics, Inc.(JSPR) | 105,175 | 55,175 | -50,000 | $2.39M | $1.04M | 0.32% | -$1.35M |
| Tessera Defense and Homeland Security Inc.(HLSQ) | 0 | 893,000 | +893,000 | $0 | $910.9K | 0.28% | +$910.9K |
| Delcath Systems, Inc.(DCTH) | 100,370 | 100,370 | 0 | $840.1K | $906.3K | 0.28% | +$66.2K |
| Climb Bio, Inc.(CLYM) | 100,000 | 175,100 | +75,100 | $711.0K | $891.3K | 0.28% | +$180.3K |
| Amylyx Pharmaceuticals, Inc.(AMLX) | 274,551 | 274,551 | 0 | $521.6K | $889.5K | 0.28% | +$367.9K |
| Proqr Thrapeutics N VSHS EURO SHS EURO | 483,583 | 483,583 | 0 | $802.7K | $880.1K | 0.27% | +$77.4K |
| Cartesian Therapeutics, Inc.(RNAC) | 242,370 | 52,193 | -190,177 | $6.55M | $841.4K | 0.26% | -$5.71M |
| Kezar Life Sciences Inc | 868,992 | 1,068,992 | +200,000 | $521.4K | $826.5K | 0.26% | +$305.1K |
| Verve Therapeutics Inc | 0 | 170,000 | +170,000 | $0 | $822.8K | 0.26% | +$822.8K |
| Immunic, Inc.(IMUX) | 493,496 | 493,496 | 0 | $547.8K | $814.3K | 0.25% | +$266.5K |
| Iteos Therapeutics Inc | 78,574 | 78,574 | 0 | $1.17M | $802.2K | 0.25% | -$363.8K |
| Aerovate Therapeutics Inc | 367,965 | 367,965 | 0 | $610.8K | $769.0K | 0.24% | +$158.2K |
| Veru Inc.(VERU) | 946,382 | 946,382 | 0 | $796.2K | $727.8K | 0.23% | -$68.4K |
| Lyell Immunopharma, Inc.(LYEL) | 526,066 | 526,066 | 0 | $762.8K | $726.0K | 0.23% | -$36.8K |
| Milestone Pharmaceuticals Inc.(MIST) | 466,019 | 466,019 | 0 | $619.8K | $708.3K | 0.22% | +$88.5K |
| Acumen Pharmaceuticals, Inc.(ABOS) | 266,435 | 266,435 | 0 | $644.8K | $660.8K | 0.21% | +$16.0K |
| Inhibrx Biosciences, Inc.(INBX) | 230,000 | 42,123 | -187,877 | $3.26M | $659.6K | 0.20% | -$2.60M |
| Allakos Inc | 972,675 | 972,675 | 0 | $972.7K | $635.4K | 0.20% | -$337.3K |
| Immatics N.V.SHS(IMTX) | 49,415 | 49,415 | 0 | $574.2K | $563.8K | 0.18% | -$10.4K |
| Nyxoah S ASHS SHS | 50,699 | 50,699 | 0 | $356.9K | $484.2K | 0.15% | +$127.3K |
| Ventyx Biosciences Inc | 442,647 | 192,647 | -250,000 | $1.02M | $420.0K | 0.13% | -$602.5K |
| Elevation Oncology Inc | 690,089 | 690,089 | 0 | $1.86M | $414.0K | 0.13% | -$1.45M |
| Faeth Therapeutics, Inc.(FTH) | 650,000 | 650,000 | 0 | $403.1K | $388.7K | 0.12% | -$14.4K |
| Larimar Therapeutics, Inc.(LRMR) | 323,528 | 58,528 | -265,000 | $2.35M | $383.4K | 0.12% | -$1.96M |
| Mind Medicine Mindmed Inc | 162,481 | 62,481 | -100,000 | $1.17M | $355.5K | 0.11% | -$816.0K |
| Karyopharm Therapeutics Inc.(KPTI) | 409,355 | 409,355 | 0 | $355.2K | $339.8K | 0.11% | -$15.4K |
| Chemomab Therapeutics LtdADS | 213,392 | 213,392 | 0 | $196.3K | $335.0K | 0.10% | +$138.7K |
| Voyager Therapeutics, Inc.(VYGR) | 55,857 | 55,857 | 0 | $441.8K | $326.8K | 0.10% | -$115.1K |
| Rapt Therapeutics Inc | 154,625 | 154,625 | 0 | $471.6K | $310.8K | 0.10% | -$160.8K |
| Anebulo Pharmaceuticals Inc | 157,862 | 157,862 | 0 | $431.0K | $304.7K | 0.09% | -$126.3K |
| Protara Therapeutics, Inc.(TARA) | 180,712 | 155,712 | -25,000 | $375.9K | $285.0K | 0.09% | -$90.9K |
| Lyra Therapeutics Inc | 1,056,829 | 1,056,829 | 0 | $292.4K | $271.6K | 0.08% | -$20.8K |
| Aeon Biopharma IncCL A | 257,977 | 257,977 | 0 | $270.9K | $270.9K | 0.08% | $0 |
| Fulcrum Therapeutics, Inc.(FULC) | 0 | 75,000 | +75,000 | $0 | $267.8K | 0.08% | +$267.8K |
| MacroGenics, Inc.(MGNX) | 200,079 | 80,079 | -120,000 | $850.3K | $263.5K | 0.08% | -$586.9K |
| Hookipa Pharma Inc | 0 | 53,076 | +53,076 | $0 | $228.2K | 0.07% | +$228.2K |
| Nuvation Bio Inc.CL A(NUVB) | 358,282 | 83,282 | -275,000 | $1.05M | $190.7K | 0.06% | -$855.5K |
| Tempest Therapeutics, Inc.(TPST) | 105,600 | 105,600 | 0 | $231.3K | $147.8K | 0.05% | -$83.4K |
| Relmada Therapeutics, Inc.(RLMD) | 40,369 | 40,369 | 0 | $121.1K | $130.8K | 0.04% | +$9.7K |
| Stoke Therapeutics, Inc.(STOK) | 6,816 | 6,816 | 0 | $92.1K | $83.8K | 0.03% | -$8.3K |
| Synlogic, Inc.(SYBX) | 20,448 | 20,448 | 0 | $30.7K | $30.5K | 0.01% | -$205 |
| CytomX Therapeutics, Inc.(CTMX) | 8,924 | 8,924 | 0 | $10.9K | $10.5K | 0.00% | -$358 |
| 4d Molecular Therapeutics In | 0 | 39 | +39 | $0 | $421 | 0.00% | +$421 |
| Annexon, Inc.(ANNX) | 380,000 | 0 | -380,000 | $1.86M | $0 | — | -$1.86M |
| Arcutis Biotherapeutics, Inc.(ARQT) | 489,642 | 0 | -489,642 | $4.55M | $0 | — | -$4.55M |
| Brainstorm Cell Therapeutics | 90,242 | 0 | -90,242 | $30.5K | $0 | — | -$30.5K |
| Cybin D/B/A Helus Pharma(HELP) | 13,953,488 | 0 | -13,953,488 | $3.78M | $0 | — | -$3.78M |